Hansa Biopharma AB (HNSA) NPV

Sell:26.00 SEKBuy:26.20 SEKPrice increased0.92 SEK (3.67%)

Prices delayed by at least 15 minutes
Sell:26.00 SEK
Buy:26.20 SEK
Change:Price increased0.92 SEK (3.67%)
Deal now
Prices delayed by at least 15 minutes
Sell:26.00 SEK
Buy:26.20 SEK
Change:Price increased0.92 SEK (3.67%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open25.00 SEK
Previous close25.10 SEK
Market capSEK 2.55bn
P/E ratio-
Volume638,244
Dividend yield0.00%
EMS-

Company information

Hansa Biopharma AB, formerly Hansa Medical AB, is a Sweden-based biopharmaceutical company with focus on immunomodulatory enzymes for treatment and prevention of rare and severe autoimmune conditions and transplant ...

  • LocationSweden
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencySEK
  • Shares in issue103.79m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.